BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9590150)

  • 1. High prevalence of thrombocytopenia in SLE patients with a high level of anticardiolipin antibodies combined with lupus anticoagulant.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Toku M; Tada H; Yamaguti K; Koike T; Kanakura Y; Kitani T; Amino N
    Am J Hematol; 1998 May; 58(1):55-60. PubMed ID: 9590150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of arterial thrombosis in patients with anticardiolipin antibodies and lupus anticoagulant.
    Nojima J; Suehisa E; Akita N; Toku M; Fushimi R; Tada H; Kuratsune H; Machii T; Kitani T; Amino N
    Br J Haematol; 1997 Mar; 96(3):447-50. PubMed ID: 9054646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association between antiphospholipid antibodies and arterial or venous thrombosis/thrombocytopenia].
    Nojima J; Suehisa E; Kuratsune H; Amino N
    Rinsho Byori; 1998 Dec; 46(12):1181-7. PubMed ID: 9916502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome.
    Gattorno M; Buoncompagni A; Molinari AC; Barbano GC; Morreale G; Stalla F; Picco P; Mori PG; Pistoia V
    Br J Rheumatol; 1995 Sep; 34(9):873-81. PubMed ID: 7582730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
    Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus.
    Wong KL; Liu HW; Ho K; Chan K; Wong R
    J Rheumatol; 1991 Aug; 18(8):1187-92. PubMed ID: 1941822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
    Jouhikainen T; Julkunen H; Vaarala O; Leirisalo-Repo M; Stephansson E; Vahtera E; Palosuo T; Myllylä G
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications.
    Nojima J; Kuratsune H; Suehisa E; Futsukaichi Y; Yamanishi H; Machii T; Iwatani Y; Kanakura Y
    Clin Chem; 2001 Jun; 47(6):1008-15. PubMed ID: 11375285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of deep venous thrombosis in the lower limbs and the pelvis and pulmonary embolism in patients with positive antiphospholipid antibodies.
    Kinuya K; Kakuda K; Matano S; Sato S; Sugimoto T; Asakura H; Kinuya S; Michigishi T; Tonami N
    Ann Nucl Med; 2001 Dec; 15(6):495-7. PubMed ID: 11831396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodular regenerative hyperplasia of the liver in systemic lupus erythematosus. The relationship with anticardiolipin antibody and lupus anticoagulant.
    Sekiya M; Sekigawa I; Hishikawa T; Iida N; Hashimoto H; Hirose S
    Scand J Rheumatol; 1997; 26(3):215-7. PubMed ID: 9225878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
    Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
    Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?
    Gómez-Puerta JA; Martín H; Amigo MC; Aguirre MA; Camps MT; Cuadrado MJ; Hughes GRV; Khamashta MA
    Medicine (Baltimore); 2005 Jul; 84(4):225-230. PubMed ID: 16010207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis.
    Wahl DG; Guillemin F; de Maistre E; Perret C; Lecompte T; Thibaut G
    Lupus; 1997; 6(5):467-73. PubMed ID: 9229367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-immunological aspects of antiphospholipid syndrome].
    Reshetniak TM; Alekberova ZS; Aleksandrova EN
    Vestn Ross Akad Med Nauk; 2003; (7):31-4. PubMed ID: 12934468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody.
    Matsuda J; Saitoh N; Gohchi K; Gotoh M; Tsukamoto M
    Am J Hematol; 1994 Sep; 47(1):56-8. PubMed ID: 8042617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
    Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.